Form D · Biotechnology

Exogenesis Corp

Billerica, MA · CIK 0001351726

Offering snapshot reported Nov 30, 2010 · SEC filing

Reported sold
$3.19M
Offering amount: $20M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 16, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 30, 2010Initial$3,189,600No comparison10SEC filing
Aug 10, 2010Amendment$4,563,929$883,687vs Jun 10, 201035SEC filing
Jun 10, 2010Initial$3,680,242No comparison7SEC filing
Aug 8, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jul 12, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jan 25, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$225K (estimated)
Form D file number
021-151149
The Finders Fee plus warrants were paid to the the entity identified in Item 12 only in connection with sales to investors outside the United States.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
NEF LLCNone

Source: Form D, filed Nov 30, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael O'malley Director
Edward J. Stewart Director
Richard Svrluga Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
10 Manning Road
Billerica, MA, 01821